Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Moderna's zika vaccine shows promise in phase 2 trial

NCT ID NCT04917861

First seen Oct 31, 2025 · Last updated Jun 19, 2026 · Updated 35 times

Summary

This study tested an experimental Zika vaccine (mRNA-1893) in 808 healthy adults aged 18 to 65. The goal was to check if the vaccine is safe and triggers a strong immune response. Participants received either the vaccine or a placebo, and researchers monitored side effects and antibody levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ZIKA VIRUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Benchmark Research - Fort Worth

    Fort Worth, Texas, 76135, United States

  • Carribean Medical Research

    San Juan, PR, 00918, Puerto Rico

  • Clinical Research Puerto Rico, Inc.

    Guayama, PR, 00784, Puerto Rico

  • Clinical Research Puerto Rico, Inc.

    San Juan, PR, 00909, Puerto Rico

  • GCM Medical Group, PSC

    San Juan, PR, 00917, Puerto Rico

  • Johnson County Clin-Trials

    Lenexa, Kansas, 66219, United States

  • Latin Clinical Trial Center, Inc.

    San Juan, PR, 00909, Puerto Rico

  • Meridian Clinical Research (Sioux City, IA)

    Sioux City, Iowa, 51106, United States

  • Ponce Medical School Foundation, Inc.

    Ponce, PR, 00713, Puerto Rico

  • Ponce Medical School Foundation, Inc.

    Ponce, PR, 00716, Puerto Rico

  • University of Puerto Rico

    San Juan, PR, 00935, Puerto Rico

Conditions

The condition(s) this trial relates to.

Zika virus infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.